Every Day Matters

We are developing precision-engineered immunotherapies to transform the lives of patients so they can focus on what really counts.

Precision-engineering immunotherapies to transform the lives of patients so they can focus on what really counts.

Precision-engineering immunotherapies to transform the lives of patients so they can focus on what really counts.

Our bispecific molecules are designed to stimulate the immune system without causing systemic safety issues.

Our Programs

Our current development programs are focused on selectively modulating T cells to fight cancer and autoimmune diseases.

Our first clinical trial is evaluating our lead tumor-activated T cell engager (TRACTr) to address prostate cancer.